Literature DB >> 8275415

Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.

W J Lennington1, R A Jensen, L W Dalton, D L Page.   

Abstract

BACKGROUND: The increased prevalence of ductal carcinoma in situ (DCIS) has produced a growing awareness of the importance of its diverse patterns. These differences in pattern have become clinically significant as predictive indicators of success for planned local excisions of small DCIS lesions.
METHODS: The authors reviewed 100 sequentially collected DCIS cases from a consultation practice. Recognizing the bias of such a series toward exclusion of easily recognizable comedo DCIS, the authors investigated the spectrum of mixed pattern lesions to identify variations and common features in the architectural arrangement of the various histologic patterns.
RESULTS: Patterns of atypical ductal hyperplasia (ADH) with specific criteria of recognition were intermixed in 17 cases (11 cribriform, 1 solid, 1 micropapillary, 4 mixed). Thirty-three cases of DCIS consisted of mixed patterns of comedo and noncomedo types. No case of comedo DCIS with associated areas of ADH was identified. In all cases of combined DCIS and ADH, the more advanced patterns of DCIS were present in the central portion of the lesion, with the ADH components arranged peripherally. This tendency for the more severely atypical areas to be located centrally was present throughout the study.
CONCLUSIONS: Different patterns of DCIS are frequently present within individual lesions (46 of 100), and the more advanced features of architectural atypia are regularly present centrally. This strongly supports the hypothesis that these lesions develop from a central focus and expand peripherally. Also, those lesions with low-grade DCIS at the periphery may be as amenable to local excision for cure as purely low-grade lesions.

Entities:  

Mesh:

Year:  1994        PMID: 8275415     DOI: 10.1002/1097-0142(19940101)73:1<118::aid-cncr2820730121>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

Review 1.  The p53 tumor suppressor gene in ductal carcinoma in situ of the breast.

Authors:  J F Simpson; D L Page
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters.

Authors:  Naoko Mori; Hideki Ota; Shunji Mugikura; Chiaki Takasawa; Junya Tominaga; Takanori Ishida; Mika Watanabe; Kei Takase; Shoki Takahashi
Journal:  Eur Radiol       Date:  2013-06-04       Impact factor: 5.315

3.  Surgical biopsy findings in patients with atypical hyperplasia diagnosed by stereotaxic core needle biopsy.

Authors:  I Tocino; B M Garcia; D Carter
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

4.  Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast.

Authors:  C M Quinn; J L Ostrowski
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

5.  C-Erb-b2 oncogene expression in intraductal proliferative lesions of the breast.

Authors:  Filiz Eren; Zerrin Calay; Haydar Durak; Bülent Eren; Nil Comunoğlu; Ovgü Aydin
Journal:  Bosn J Basic Med Sci       Date:  2012-02       Impact factor: 3.363

6.  [Prognostic factors in ductal carcinoma in situ].

Authors:  A Lebeau
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

Review 7.  Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.

Authors:  Vidya C Sinha; Helen Piwnica-Worms
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-09-07       Impact factor: 2.673

8.  Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors.

Authors:  A G A Selim; G El-Ayat; C A Wells
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

9.  Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy.

Authors:  Byung Joo Chae; Ahwon Lee; Byung Joo Song; Sang Seol Jung
Journal:  World J Surg Oncol       Date:  2009-10-23       Impact factor: 2.754

10.  Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors.

Authors:  David E Axelrod; Naomi Miller; Judith-Anne W Chapman
Journal:  Biomed Inform Insights       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.